# Trial to Assess the Everolimus-Eluting Coronary Stent System (PROMUS Element) for Coronary Revascularization

> **NCT01342822** · — · UNKNOWN · sponsor: **European Cardiovascular Research Center** · enrollment: 2980 (estimated)

## Conditions studied

- Ischemic Heart Disease
- Coronary Artery Stenosis

## Interventions

- **DEVICE:** Angioplasty (PROMUS Element™, and Xience™ Prime stent)

## Key facts

- **NCT ID:** NCT01342822
- **Lead sponsor:** European Cardiovascular Research Center
- **Sponsor class:** NETWORK
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2010-10
- **Primary completion:** 2014-03
- **Final completion:** 2014-03
- **Target enrollment:** 2980 (ESTIMATED)
- **Last updated:** 2012-03-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01342822

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01342822, "Trial to Assess the Everolimus-Eluting Coronary Stent System (PROMUS Element) for Coronary Revascularization". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01342822. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*